• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Grok 4 aids Exit
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Investor Relations

Investor Relations

Edit

This page has the following sub pages.

  • Re: Henri Cukierman
  • Dr. Paolo Lombardi & Dr. Cristina Geroni
  • Exchange with Haim Kravitz
  • Maxim Group LLC
  • Exchange with R. Newman
  • Dr. Laurent Choppe
  • Silvester Werring
  • Peter Corne
  • Investment Sources in Israel

Like this:

Like Loading...

This page has the following sub pages.

  • Re: Henri Cukierman
  • Dr. Paolo Lombardi & Dr. Cristina Geroni
  • Exchange with Haim Kravitz
  • Maxim Group LLC
  • Exchange with R. Newman
  • Dr. Laurent Choppe
  • Silvester Werring
  • Peter Corne
  • Investment Sources in Israel

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 9,316 other subscribers
  • Recent Posts

    • Marquee Followers 80% Healthcare Persons and Institutions for @AVIVA1950 and @Pharma_BI December 8, 2025
    • Exploratory Protocol for Comparison of NLP to LLM on Same Oncology Slice December 8, 2025
    • Valuation Models per Ten Digital IP Asset Classes in LPBI Group’s Portfolio of IP December 8, 2025
    • Protected: How will gold and silver medal for Grok be achieved for Domain-aware “AI in Health”: Pharmaceutical/BioPharma, Medical/Diagnosis and Therapeutics, Life Sciences/Genomics and BioMed/Biotech/Medtech December 5, 2025
    • Generative AI Providers: Open Source and Closed source, Google’s JAX AI stack versus @xAI and @Grok December 3, 2025
    • In Memoriam to Michael R. Bristow, MD, PhD, A Visionary Leader in Heart Failure (HF) Cardiology December 1, 2025
    • AI and Health Day @AIW25, AI Week, December 9 – December 11, 2025, Tel Aviv University December 1, 2025
    • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class X: +300 Audio Podcasts Library: Interviews with Scientific Leaders November 22, 2025
    • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class V: 7,500 Biological Images in LPBI Group’s Digital Art Media Gallery, as Prior Art November 22, 2025
    • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class III: 100 e-Proceedings and 50 Tweet Collections of Top Biotech and Medical Global Conferences, 2013-2025 November 22, 2025
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d